Last reviewed · How we verify
NCT03843840
Dual Wavelength OCT
trial testing Combined Coaxial Optical Coherence Tomography in AMD in 60 participants. Completed in 21 October 2020.
30 November 2019
Quick facts
| Lead sponsor | Moorfields Eye Hospital NHS Foundation Trust |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 15 February 2019 |
| Primary completion | 30 November 2019 |
| Estimated completion | 21 October 2020 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Combined Coaxial Optical Coherence Tomography
Conditions studied
- AMD — all drugs for AMD →
- Diabetic Retinopathy — all drugs for Diabetic Retinopathy →
- Retinal Degeneration — all drugs for Retinal Degeneration →
- Retinal Dystrophies — all drugs for Retinal Dystrophies →
Sponsor
Moorfields Eye Hospital NHS Foundation Trust
Who can join
18 and older, any sex, with AMD or Diabetic Retinopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is the evaluation of a combined coaxial optical coherence tomography (OCT) system to image retina/choroid and to evaluate if post processing of the data can give us insights into property of the tissue imaged.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03843840
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for AMD
Currently open trials in the same condition.
- NCT07216677 — A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseas · active not recruiting
- NCT01432847 — Cell Collection to Study Eye Diseases · recruiting
Other Moorfields Eye Hospital NHS Foundation Trust trials
Trials by the same sponsor.
- NCT06974162 — Metagenomics for Ocular Inflammation · recruiting
- NCT06689397 — Investigating Epstein-Barr Virus Associated Conjunctivitis · enrolling by invitation
- NCT06528509 — AI-Enhanced Consent for Cataract Surgery · NA · not yet recruiting
- NCT03102138 — Retinal Pigment Epithelium Safety Study for Patients in B4711001 · active not recruiting
- NCT05543889 — Evaluation of Clinical Decisions and Assessment of Those at Risk of Primary Angle Closure by Community Optometrists · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03843840 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Moorfields Eye Hospital NHS Foundation Trust
- Last refreshed: 12 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03843840.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing